Free Trial

Greenbrook TMS Q3 2023 Earnings Report

$0.01 -0.01 (-35.29%)
(As of 12/20/2024 05:18 PM ET)

Greenbrook TMS EPS Results

Actual EPS
-$0.22
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Greenbrook TMS Revenue Results

Actual Revenue
$18.04 million
Expected Revenue
$19.50 million
Beat/Miss
Missed by -$1.46 million
YoY Revenue Growth
N/A

Greenbrook TMS Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

The #1 Coin for November 2024 (Ad)

Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…

You can get access to the report by clicking here now…

Greenbrook TMS Earnings Headlines

Crypto’s hidden gem + greatest crypto bull run in history = $$$?
You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.
See More Greenbrook TMS Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Greenbrook TMS? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Greenbrook TMS and other key companies, straight to your email.

About Greenbrook TMS

Greenbrook TMS (NASDAQ:GBNHF), together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared neurostimulation therapy for the treatment of major depressive disorder and other mental health disorders. The company also offers Spravato, an esketamine nasal spray; and other treatment modalities for the treatment of depression and related psychiatric services. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.

View Greenbrook TMS Profile

More Earnings Resources from MarketBeat

Upcoming Earnings